Onsite Cannabis and DOA Workplace Testing
The AfimaCheck Reader empowers workplace drug testing enabling zero-tolerance cannabis policies. Our technology is able to detect and quantify the presence of cannabis in oral fluid at concentrations as low as 2ng/ml.
Robust Technology
Our patented thermophotonic lock-in technology allows quantitative measurements of existing Lateral Flow Assays. We are unlocking unprecedented detection sensitivity in low-cost paper-based testing.